Michael J. Garlepp

1.9k total citations
36 papers, 1.5k citations indexed

About

Michael J. Garlepp is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Michael J. Garlepp has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Epidemiology and 12 papers in Immunology. Recurrent topics in Michael J. Garlepp's work include Inflammatory Myopathies and Dermatomyositis (11 papers), Cancer Research and Treatments (7 papers) and Occupational and environmental lung diseases (7 papers). Michael J. Garlepp is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (11 papers), Cancer Research and Treatments (7 papers) and Occupational and environmental lung diseases (7 papers). Michael J. Garlepp collaborates with scholars based in Australia, United States and Qatar. Michael J. Garlepp's co-authors include Frank Mastaglia, Frank Christiansen, P. J. Zilko, Campbell S. Witt, Beverley A. Phillips, Chee Choy Kok, S. Mallal, Patricia Price, Martyn A. French and D. Sayer and has published in prestigious journals such as Annals of Neurology, Biochemical and Biophysical Research Communications and Immunological Reviews.

In The Last Decade

Michael J. Garlepp

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Garlepp Australia 20 521 391 315 289 236 36 1.5k
M.J. Garlepp Australia 18 397 0.8× 253 0.6× 185 0.6× 171 0.6× 184 0.8× 38 1.2k
Vincent Hurez United States 29 1.4k 2.7× 230 0.6× 154 0.5× 601 2.1× 141 0.6× 60 2.6k
Katri Vuopala Finland 23 531 1.0× 89 0.2× 273 0.9× 525 1.8× 54 0.2× 37 1.3k
Dana Thomasová Germany 18 488 0.9× 126 0.3× 189 0.6× 676 2.3× 75 0.3× 24 1.4k
Wenwu Zhai United States 16 365 0.7× 93 0.2× 77 0.2× 543 1.9× 68 0.3× 19 1.3k
Stefan Ries Germany 23 158 0.3× 189 0.5× 170 0.5× 801 2.8× 27 0.1× 36 1.5k
Jianmei W. Leavenworth United States 23 825 1.6× 82 0.2× 116 0.4× 413 1.4× 103 0.4× 52 1.5k
Mark Allegretta United States 20 986 1.9× 199 0.5× 48 0.2× 492 1.7× 101 0.4× 32 1.9k
Neda Farahi United Kingdom 17 697 1.3× 148 0.4× 286 0.9× 375 1.3× 73 0.3× 30 1.5k
T Matsuda Japan 7 1.2k 2.3× 180 0.5× 88 0.3× 668 2.3× 177 0.8× 9 2.4k

Countries citing papers authored by Michael J. Garlepp

Since Specialization
Citations

This map shows the geographic impact of Michael J. Garlepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Garlepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Garlepp more than expected).

Fields of papers citing papers by Michael J. Garlepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Garlepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Garlepp. The network helps show where Michael J. Garlepp may publish in the future.

Co-authorship network of co-authors of Michael J. Garlepp

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Garlepp. A scholar is included among the top collaborators of Michael J. Garlepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Garlepp. Michael J. Garlepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fox, Simon A., et al.. (2012). Regulated chemokine gene expression in mouse mesothelioma and mesothelial cells: TNF-α upregulates both CC and CXC chemokine genes. Oncology Reports. 28(2). 707–713. 7 indexed citations
2.
Mastaglia, Frank, Merrilee Needham, Adrian P. Scott, et al.. (2009). Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype. Neuromuscular Disorders. 19(11). 763–765. 43 indexed citations
3.
Garlepp, Michael J. & Frank Mastaglia. (2008). Inclusion body myositis: new insights into pathogenesis. Current Opinion in Rheumatology. 20(6). 662–668. 9 indexed citations
4.
Needham, Merrilee, Amanda J. Hooper, Ian James, et al.. (2008). Apolipoprotein ε alleles in sporadic inclusion body myositis: A reappraisal. Neuromuscular Disorders. 18(2). 150–152. 12 indexed citations
5.
Huang, Yue, Glenda M. Halliday, Himesha Vandebona, et al.. (2007). Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease. Movement Disorders. 22(7). 982–989. 31 indexed citations
6.
Fox, Simon A., et al.. (2005). Cisplatin and TNF-α downregulate transcription of Bcl-xL in murine malignant mesothelioma cells. Biochemical and Biophysical Research Communications. 337(3). 983–991. 11 indexed citations
7.
Fox, Simon A., et al.. (2004). Identification of differentially expressed genes in murine mesothelioma cell lines of differing tumorigenicity using suppression subtractive hybridization. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1688(3). 237–244. 11 indexed citations
8.
Mastaglia, Frank, Michael J. Garlepp, Beverley A. Phillips, & P. J. Zilko. (2003). Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects. Muscle & Nerve. 27(4). 407–425. 137 indexed citations
9.
Kok, Chee Choy, Silvana Gaudieri, Ralph N. Martins, et al.. (2000). Mitochondrial DNA variants in inclusion body myositis. Neuromuscular Disorders. 10(8). 604–611. 14 indexed citations
10.
Caminschi, Irina, Eleni Venetsanakos, Clement C. Leong, et al.. (1999). Cytokine Gene Therapy of Mesothelioma: Immune and Antitumor Effects of Transfected Interleukin-12. American Journal of Respiratory Cell and Molecular Biology. 21(3). 347–356. 27 indexed citations
11.
Robinson, B. W., Sutapa Mukherjee, Andrew R. Davidson, et al.. (1998). Cytokine Gene Therapy or Infusion as Treatment for Solid Human Cancer. Journal of Immunotherapy. 21(3). 211–217. 54 indexed citations
12.
Caminschi, Irina, Eleni Venetsanakos, Clement C. Leong, et al.. (1998). Interleukin-12 Induces an Effective Antitumor Response in Malignant Mesothelioma. American Journal of Respiratory Cell and Molecular Biology. 19(5). 738–746. 38 indexed citations
13.
Phillips, Beverley A., P. J. Zilko, Michael J. Garlepp, & Frank Mastaglia. (1998). Frequency of relapses in patients with polymyositis and dermatomyositis. Muscle & Nerve. 21(12). 1668–1672. 33 indexed citations
14.
Watkins, D. Neil, Michael J. Garlepp, & Philip J. Thompson. (1997). Regulation of the inducible cyclo‐oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. British Journal of Pharmacology. 121(7). 1482–1488. 107 indexed citations
15.
Lawson, Malcolm, Hyacinth Tabarias, Michael J. Garlepp, et al.. (1997). Myositis Induced by Naked DNA Immunization with the Gene for Histidyl-tRNA Synthetase. Human Gene Therapy. 8(12). 1469–1480. 24 indexed citations
16.
Leong, Clement C., et al.. (1997). Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma. International Journal of Cancer. 71(3). 476–482. 21 indexed citations
17.
Lawson, C M, et al.. (1996). Sequence and polymorphism analysis of the murine gene encoding histidyl-tRNA synthetase. Gene. 178(1-2). 151–156. 5 indexed citations
18.
Garlepp, Michael J., et al.. (1995). Apolipoprotein E ϵ4 in inclusion body myositis. Annals of Neurology. 38(6). 957–959. 33 indexed citations
19.
Christmas, T.I., Linda S. Manning, Michael J. Garlepp, Arthur W. Musk, & B. W. Robinson. (1993). Effect of Interferon-α 2a Malignant Mesothelioma. Journal of Interferon Research. 13(1). 9–12. 60 indexed citations
20.
Rakoczy, Piroska E., Michael J. Garlepp, & Ian J. Constable. (1992). HLA DQA tissue typing of cadaveric eye bank donor material with polymerase chain reaction. Current Eye Research. 11(5). 445–452. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.J. Garlepp Breakdown of academic impact, for papers by Vincent Hurez Breakdown of academic impact, for papers by Katri Vuopala Breakdown of academic impact, for papers by Dana Thomasová Breakdown of academic impact, for papers by Wenwu Zhai Breakdown of academic impact, for papers by Stefan Ries Breakdown of academic impact, for papers by Jianmei W. Leavenworth Breakdown of academic impact, for papers by Mark Allegretta Breakdown of academic impact, for papers by Neda Farahi Breakdown of academic impact, for papers by T Matsuda
Rankless by CCL
2026